Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.

Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA.

Oncogene. 2014 Jan 23;33(4):411-20. doi: 10.1038/onc.2012.607. Epub 2013 Jan 14.

PMID:
23318423
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.

Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M, Golemis EA.

Cancer Res. 2010 Nov 1;70(21):8907-16. doi: 10.1158/0008-5472.CAN-10-0353. Epub 2010 Oct 12.

PMID:
20940402
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

NEDD9 promotes oncogenic signaling in mammary tumor development.

Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA.

Cancer Res. 2009 Sep 15;69(18):7198-206. doi: 10.1158/0008-5472.CAN-09-0795. Epub 2009 Sep 8.

PMID:
19738060
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

PMID:
16651418
[PubMed - indexed for MEDLINE]
Free Article
5.

The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.

Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE.

Cancer Res. 2008 Oct 1;68(19):7711-7. doi: 10.1158/0008-5472.CAN-08-1949.

PMID:
18829523
[PubMed - indexed for MEDLINE]
Free Article
6.

Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA.

Oncogene. 2006 Jun 1;25(23):3325-34. Epub 2006 Jan 23.

PMID:
16434967
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.

Zinser GM, Welsh J.

Carcinogenesis. 2004 Dec;25(12):2361-72. Epub 2004 Aug 27.

PMID:
15333467
[PubMed - indexed for MEDLINE]
Free Article
8.

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, Chen H.

Oncogene. 2012 May 24;31(21):2614-26. doi: 10.1038/onc.2011.439. Epub 2011 Sep 26.

PMID:
21996747
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.

Cancer Res. 2007 Sep 15;67(18):8671-81.

PMID:
17875707
[PubMed - indexed for MEDLINE]
Free Article
10.

Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

Campbell MJ, Wollish WS, Lobo M, Esserman LJ.

In Vitro Cell Dev Biol Anim. 2002 Jun;38(6):326-33.

PMID:
12513120
[PubMed - indexed for MEDLINE]
11.

P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.

McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T.

Breast Cancer Res. 2010;12(5):R73. doi: 10.1186/bcr2643. Epub 2010 Sep 22.

PMID:
20860838
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice.

Wong PS, Matsumura F.

BMC Cancer. 2007 Jul 17;7:130.

PMID:
17640349
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.

Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL.

Mol Cell Biol. 2002 Apr;22(7):2204-19.

PMID:
11884607
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.

Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM.

Breast Cancer Res. 2009;11(4):R61. doi: 10.1186/bcr2352. Epub 2009 Aug 24.

PMID:
19703301
[PubMed - indexed for MEDLINE]
Free PMC Article
15.
16.

The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.

Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM.

Cancer Res. 1998 Dec 1;58(23):5500-6.

PMID:
9850086
[PubMed - indexed for MEDLINE]
Free Article
17.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.

PMID:
18079969
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.

Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL.

Horm Cancer. 2012 Dec;3(5-6):227-39. doi: 10.1007/s12672-012-0122-x. Epub 2012 Sep 12.

PMID:
22968785
[PubMed - indexed for MEDLINE]
19.

MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.

Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.

Oncogene. 2001 Sep 20;20(42):6009-17.

PMID:
11593408
[PubMed - indexed for MEDLINE]
Free Article
20.

Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.

Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD.

Cancer Res. 2004 Jan 1;64(1):169-79.

PMID:
14729621
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk